Bicara Therapeutics
BCAX | NASDAQ
$9.75
-$0.27 (-2.69%)
At close: Nov 16, 2026, 4:00 PM ET
$9.75
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Bicara Therapeutics Institutional Ownership
Institutional ownership explainedInstitutional Ownership
Net InflowTotal Institutions
184
Total Ownership
119.50%
Capital Flow
+$746.74M
Shares Change
+1.3M
Ownership Distribution
Institutions (99.99%)
Others (0.01%)
Institutional Sentiment
Overall: neutralEquity Sentiment & Activity
bullishNew Positions
43
Increased Positions
114
Reduced Positions
39
Closed Positions
12
New (43)
Increased (114)
Reduced (39)
Closed (12)
Options Sentiment & Activity
bearishPut/Call Ratio
2.949
Call Flow
64,100
Put Flow
189,000
Calls (25%)
Puts (75%)
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Ra Capital Management, L.p. | 10.68% -10.61% | 1.87% +22.42% | 7.26M 0.00% | 215.43M +49.27% | |
| T. Rowe Price Investment Management, Inc. | 9.33% -14.23% | 0.12% +36.34% | 6.34M -4.05% | 188.19M +43.23% | |
| Siren, L.l.c. | 8.25% -13.69% | 3.37% +5.22% | 5.6M -3.45% | 166.35M +44.13% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove BCAX